Treatment of Pseudomonas aeruginosa eye infections often becomes a challenge due to the ability of this bacterium to be resistant to antibiotics via intrinsic and acquired mechanisms. Transfer of resistance due to interchangeable genetic elements is an important mechanism for the rapid transfer of antibiotic resistance in this pathogen. As a result, drug-resistant strains are becoming increasingly prevalent worldwide. This review systematically analyses data from recent publications to describe the global prevalence and antibiotic sensitivity of ocular P. aeruginosa. Thirty-seven studies were selected for review from PubMed-based searches using the criteria 'microbial keratitis OR eye infection AND Pseudomonas aeruginosa AND antibiotic resistance' and limiting to papers from 2011 onward, to demonstrate the antibiotic resistance from isolates from around the world. Subsequently, we reviewed the ways in which P. aeruginosa can become resistant to antibiotics. Both the rate of isolation of bacteria in general (79 per cent of cases), and prevalence of P. aeruginosa (68 per cent of all isolates) were highest in contact lens-related microbial keratitis. The average resistance rate to common ocular antibiotics such as ciprofloxacin (9 per cent), gentamicin (22 per cent) and ceftazidime (13 per cent) remained relatively low. However, there were large variations in resistance rates reported in studies from different countries, for example resistance to ciprofloxacin reached up to 33 per cent. We next reviewed the types of mobile genetic elements (MGEs) such as plasmids, integrons and transposons that are frequently associated with drug resistance in P. aeruginosa. MGEs are important for the transmission of resistance to beta-lactams and aminoglycosides and recently have been shown to be potential factors for the transmission of fluoroquinolone resistance. Studies on the molecular mechanisms of resistance transfer in ocular P. aeruginosa have begun to be reported and will provide valuable information on the emergence of new antibiotic resistance and potential to treat resistant strains.
The opportunistic pathogen Pseudomonas aeruginosa is well-known for its remarkable adaptation to different environments. With diverse metabolic pathways and a large repertoire of pathogenic mechanisms, this Gram-negative bacillus is able to survive and grow under a broad range of environmental conditions, including but not limited to: on medical equipment, 1 in water systems, 2 in ventilators 3 and in the presence of some disinfectants. 4 Diseases associated with this bacterium range from mild folliculitis to life-threatening pneumonia and septicaemia. 5 Predisposing factors for Pseudomonas infections include a compromised immune system and impaired anatomical structures caused by, among other things, burns, cystic fibrosis and mechanical abrasions such as wearing of contact lenses. 6, 7 P. aeruginosa is one of the most common pathogens causing visionthreatening eye infections. [7] [8] [9] [10] Pre-existing contact lens wear, ocular surface disease, ocular trauma and prior ocular surgery are risk factors for developing Pseudomonas keratitis. 7, 11 Reduced susceptibility to antibiotics and disinfectants has been widely reported in clinical isolates of P. aeruginosa, [12] [13] [14] which makes infection with this bacterium difficult to treat. P. aeruginosa is not only naturally immune to many antimicrobials due to chromosomally encoded resistance genes, 15, 16 but also has the capacity to acquire mobile genetic elements (MGEs). 15, 16 This latter mechanism is important in emergence and rapid spread of drug resistance. As in systemic Pseudomonas infections, 17, 18 the rate of isolation of antibiotic-resistant P. aeruginosa has been increasing in ocular infections. 12, 13 However, very few reports describe the mechanism of resistance of ocular isolates.
Antibiotic resistance genes can originate from both pathogenic and non-pathogenic bacteria. Bacteria acquire the genes in order to survive in unfavourable conditions such as in presence of antibiotics. Plasmids and other MGEs play a vital role in this phenomenon. They act as vectors for both resistance gene capture and dissemination.and evaluates the MGE-mediated resistance to the most important anti-pseudomonas drug classes: beta-lactams, aminoglycosides and fluoroquinolones.
P. AERUGINOSA IN EYE INFECTIONS
Data on the prevalence and antibiotic sensitivity of ocular isolates of P. aeruginosa were collected from publications from 2011 to 2016. The literature was obtained from PubMed using the search keywords 'microbial keratitis OR eye infection AND Pseudomonas aeruginosa AND antibiotic resistance'. Only those articles were included that reported on isolates from the eye and for which antimicrobial resistance had been determined.
Publications with irrelevant research questions, non-English full text and/or those lacking quantitative information on resistance and sensitivity were excluded. Out of a total of 62 articles, 37 were relevant to the scope of this review. Therefore, data of those 37 papers were analysed and are summarised in this section of the review.
The rate of isolation of bacteria from ocular infections was highest in contact lens-related microbial keratitis compared to other eye infections. 19, 20 Furthermore, the prevalence of P. aeruginosa was much higher in contact lens-related microbial keratitis 19, 20 compared to other eye infections (Table 1) . A report from Australia showed culture positivity rates of 65 per cent from microbial keratitis and P. aeruginosa was the most common isolate. 11 However, obtaining a positive culture from clinical samples depends on many factors: antibiotic treatment before collection of sample, appropriate culture conditions, ability of infecting microbes to grow artificially, robustness of inflammatory response, and involvement of agents other than bacteria such as viruses and protozoa, and these may be the reasons for lower culture rates in other studies. [21] [22] [23] [24] The literature covered data from 17 countries (Table 2) , and a higher culture positive rate was noted in the Netherlands (78.9 per cent) which also had the highest prevalence of P. aeruginosa (68.2 per cent). 19 The reason for the latter finding is probably due to the study examining only cases of microbial keratitis. A relatively high prevalence was observed in a study from Pakistan 13 perhaps because of selection of isolates only from contact lenses. The overall antibiotic sensitivity pattern of P. aeruginosa was determined by compiling information on the total number of isolates tested for individual antibiotics and the number of resistant or susceptible isolates to each antibiotic. Ciprofloxacin was the most frequently tested antibiotic, followed by gentamicin and ceftazidime. Levofloxacin was the most effective antibiotic for ocular isolates of P. aeruginosa followed by ciprofloxacin and amikacin with respective sensitivities of 94.6, 90.9 and 90.2 per cent ( Figure 1) .
The sensitivity rate varied greatly between countries. For example, studies from Ethiopia (66.7 per cent), 26 China (50 per cent), 28 Pakistan (40 per cent), 13 Germany (53 per cent) 46 and Mexico (12 per cent) 38 had much lower sensitivity rates to gentamicin than the overall average (78.5 per cent). P. aeruginosa isolated from other body site infections often showed much higher resistance than eye isolates. In separate studies, isolates of P. aeruginosa from urinary tract infection, 56 multiple body sites of intensive care unit patients 57 and cystic fibrosis cases 58 showed only 62, 41 and 44 per cent sensitivity to ciprofloxacin, respectively.
The rate of antibiotic resistance observed in this study is close to results that were reported before 2010. 22, 59 This suggests that rate of antibiotic resistance in ocular P. aeruginosa is stable. Furthermore, reports of antibiotic resistance monitoring studies have shown that the antibiotic resistance pattern in eye isolates of P. aeruginosa has not substantially changed over this period. 53, 54, 60 However, similar to the finding of this analysis, antibiotic resistance rate was higher in certain geographical locations. 61 This trend is probably related to the extensive use of antibiotics in systemic infections and agriculture, over-the-counter availability and improper diagnosis and prophylaxis. 62 In contrast, a 10-year retrospective study of P. aeruginosa isolated from pneumonia showed that resistance to antibiotics has significantly increased over the past decade. 63 Although the resistance rate was relatively low and stable in eye isolates of P. aeruginosa, there is the possibility of transfer of resistance between eye and noneye isolates, thus leading to infections with resistance isolates. Therefore, it is necessary to monitor the mechanism of resistance transfer in eye P. aeruginosa.
MOBILE GENETIC ELEMENTS-ASSOCIATED DRUG RESISTANCE IN P. AERUGINOSA
Literature on MGE-associated drug resistance in P. aeruginosa was searched in PubMed, MEDLINE and Google. The search was performed using key terms 'Pseudomonas aeruginosa', AND 'mobile genetic elements' OR 'plasmid' OR 'integrons' OR 'transposons', AND 'antibiotic resistance', with a refinement of AND 'eye infection' after initial searches. Reference lists of all the related literature were further manually checked for relevant information on drug resistance and associated MGEs. The collected data were used to describe the MGE-associated drug resistance in P. aeruginosa. Plasmids are circular double-stranded DNA molecules auxiliary to chromosomal DNA found in many, if not all bacterial types. They are diverse in size and function. Some just carry one to two genes but others may harbour as many as 400 genes. 64 Plasmids not only exist independently of chromosomal DNA but also multiply autonomously, 65 which means several copies can be contained in one bacterial cell. They do not take part in basic cellular functions such as cell growth and multiplication; rather they often carry genetic elements that help the bacteria to survive and grow in unfavourable environmental conditions such as in the presence of lethal antibiotics.
Plasmids can encode enzymes that confer resistance to different antimicrobial substances such as antibiotics, disinfectants, heavy metals and even UV radiation. 66 Furthermore, plasmids can move with or without captured chromosomal genes from one bacterial cell to another, in a method called horizontal gene transfer. 65 If plasmids carry antibiotic resistance genes, the recipient bacteria will be able to express antibiotic resistance.
Transposons and integrons are other genetic elements that are as important as plasmids for the horizontal transfer of bacterial resistance and are common in clinical strains of P. aeruginosa. 16 Commonly called jumping genes, transposons can undergo transposition to move themselves from one location to another within the same or different DNA molecules, for example plasmids or the chromosome. 64, 67 Their size varies from as short as 1.5 kilobase pairs (kb) to as long as 26.6 kb, and they consist of an insertion sequence and at least one open reading frame. 16 The former encodes the transposase that facilitates their movement and the latter might contain gene(s) for antibiotic resistance. 16 On the other hand, integrons are gene capture systems that capture gene cassettes, including but not limited to, antibiotic resistance genes and aid their expression. 68 Integrons (Figure 2 ) can be located in plasmids or transposons. 69 The presence of MGEs in P. aeruginosa is significantly associated the multidrug resistance patterns. 71, 72 About 30-40 per cent of multidrug-resistant P. aeruginosa isolates have been recorded to carry one or more plasmids. 71, 73, 74 Variations in carriage rates of as low as 14 per cent 75 to as high as 100 per cent 76 have been reported. Moreover, the occurrence of plasmids is associated with both the nature of antibiotics and the source of isolation of the bacteria. For example, beta-lactam-resistant strains carry a higher frequency of plasmids than strains resistant to other classes of antibiotics. 73, 77 Similarly, plasmid size is generally larger in 77 Furthermore, integron-associated antibiotic resistance genes have been identified in several disease outbreaks. [78] [79] [80] [81] Reports from varying geographic locations showed about one-half of the total multidrug resistance P. aeruginosa strains carry integrons. [82] [83] [84] Resistance traits associated with MGEs indicate that they are most probably recently acquired because one strain can horizontally acquire plasmid DNA from other strains. 66 Knowledge of MGEassociated drug resistance is important to monitor resistance behaviour among eye isolates. In addition, this knowledge can be used to develop a plan to reduce antimicrobial resistance and to keep the current antibiotics effective for longer periods.
Treatment of microbial eye infections relies mostly on antibiotics from three classes, beta-lactams, aminoglycosides and fluoroquinolones. [85] [86] [87] Third generation cephalosporins, gentamicin and ciprofloxacin are the primary choices for treatment of Pseudomonal eye infections. 88 Emergence of MGE-related antibiotic resistance in P. aeruginosa outside of eyes [71] [72] [73] [74] 77 suggests that similar patterns may be present in ocular isolates.
BETA-LACTAM RESISTANCE
Beta-lactam antibiotics are the most widely used therapeutic choice for treatment of bacterial infections, accounting for 60 per cent of total antibiotics used by weight. 89 Their high effectivity, chemical diversity, comparatively low cost with minimum sideeffects make this class of antibiotics popular in treatment of microbial infections. 90 Cephalosporins such as cephazolin are commonly used beta-lactams in the treatment of eye infections. 12 They are often prescribed in combination with aminoglycosides as fortified preparations. 85 However, increased beta-lactam resistance in clinical isolates has threatened their therapeutic value. 89 Bacteria become resistant to beta-lactams by producing heterogeneous enzymes commonly called beta-lactamases. 89 These hydrolyse the beta-lactam bond (Figure 3) , which is vital for antimicrobial activity, and render the antibiotics ineffective. 91 The genes encoding betalactamase can reside on the chromosome or on MGEs (for example, plasmids). Plasmid-encoded enzymes are often expressed constitutively. 91 However, for ). The genes within the integron are: intI1 = integrase, attI = attachment gene for integron, blaVIM-1 = metallo-beta-lactamase, aadA1 = aminoglycoside adenylyltransferase, QacEdelta1 = multidrug exporter, and sul1 = dihydropteroate synthase, unknown = unknown gene, tniBdelta3 = partial sequence of putative transposase, tniA = putative transposase. 
resistance, expression is inducible. 91, 92 A classification by Bush and Jacoby, on the basis of the action of enzymes and susceptibility to beta-lactamase inhibitors, stratifies beta-lactamases into three groups (Table 3 ) and several sub-groups (not shown here). 93 Group 1 beta-lactamases are chromosome-based cephalosporinase (AmpC) and these are responsible for a low basal level of intrinsic resistance in P. aeruginosa. 94 However, its production can be induced by exposure to beta-lactams. 94 Increased production of AmpC due to mutation, coupled with efflux pumps or reduced permeability to beta lactams, may be responsible for resistance against almost all beta-lactams including carbapenems, which are otherwise resistant to inactivation by AmpC. 95 Plasmidmediated AmpC was first identified in the 1980s in Gram-negative bacteria. 96 However, unlike in Enterobacteriaceae, very few reports describe plasmid AmpC in P. aeruginosa. A report from India showed 20 per cent of burn isolates of P. aeruginosa were phenotypically positive to AmpC beta-lactamase 97 and plasmid-mediated AmpC has been recently detected in clinically isolated P. aeruginosa from China. 98 Group 2 beta-lactamases are a complex group including many families of enzymes that are encoded by genes that are transmissible. This group of enzymes includes both molecular classes A and D ( Table 3 ) that can be inhibited by beta-lactamase inhibitors. 93 The sulfhydryl reagent variable (SHV) family of group 2 beta-lactamase was derived from the chromosome of Klebsiella spp. but later incorporated into plasmids. 95 It can hydrolyse broad-spectrum penicillins such as ampicillin and piperacillin but not oxyiminosubstituted cephalosporins (ceftazidime and cefotaxime). 95 Variants of SHV (SHV-1, SHV-2, SHV-2ª, SHV-5, SHV-12) have been isolated from P. aeruginosa.
95,100,101 The TEM (Temoneira) type beta-lactamases are functionally similar to SHV and were first identified in Escherichia coli. Later, many TEM variants (TEM-1, TEM-2, TEM-4, TEM-21, TEM-24, TEM-42, TEM-116) were detected in P. aeruginosa with different enzymatic capacities. 93, 95, 102 CTX (cefotaxime) represents a new family of beta-lactamases, which are not related to the SHV or TEM types, that has the capacity to hydrolyse cefotaxime. They are also derived from the Enterobacteriaceae and were disseminated to other bacteria by horizontal gene transfer. 95 Major variants found in P. aeruginosa include CTX-M-1, CTX-M-2, CTX-M-43. 95 Beta-lactamases with the capacity to hydrolyse oxacillin are known as OXA and are predominantly isolated from P. aeruginosa. Several variants of OXA enzymes with extended spectrum have been identified in P. aeruginosa.
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Other extended spectrum betalactamases (ESBL) include PER (hydrolysed penicillins and cephalosporins), GES (hydrolysed penicillins and extendedspectrum cephalosporins) and KPC (hydrolysed carbapenems). 93 Group 3 beta-lactamases, metallo-betalactamases, are unique due to the presence of zinc at their active site. They are plasmid-mediated and highly transferable; 103 however, chromosomal integration is also common. 95 The first metallo-betalactamase (IMP-1) in P. aeruginosa was detected in Japan 103 and since then the incidence of these agents has been increasing. 104, 105 Other MGE-associated metallobeta-lactamase families include SPM, VIM and GIM. 106 These also have been detected in P. aeruginosa and their prevalence rates are gradually increasing. 89 Since mutations in the ESBL genes produce variants of enzymes with different specificities for substrates or susceptibilities to beta-lactam inhibitors, the numbers of variants are expanding.
Studies have reported the prevalence of beta-lactam resistance genes in ocular clinical isolates of P. aeruginosa, and this ranges from seven per cent to more than 75 per cent.
107-109 TEM, SHV, OX, and CTX-M have been found in the chromosome of an ocular P. aeruginosa. 110 In addition, Murugan et al. found integration of TEM-1B, PAO, OXA-50 and VIM-2 in the chromosome of multidrug-resistant P. aeruginosa strain from a keratitis patient. 111 There has been no evidence for the plasmid association of these genes in ocular isolates.
AMINOGLYCOSIDE RESISTANCE
Despite the appearance of resistance as far back as the 1960s 112 and high toxicity to eukaryotic cells, aminoglycosides (amikacin, gentamicin, kanamycin, neomycin, netilmicin, paromomycin, streptomycin and tobramycin) have been used for many years for the treatment of Pseudomonas infections. 113 Currently, resistance to aminoglycosides in P. aeruginosa is very common and is reported from all around the world. 114 Although aminoglycoside resistance in P. aeruginosa may be due to a combination of factors such as a decrease in cell permeability, increased efflux and changes in ribosomes, the most important mechanism is the enzymatic alteration of the active chemical groups in the antibiotics by aminoglycoside-modifying enzymes (AME). 115 These enzymes can modify specific amino and glycoside groups of the molecule vital for the activity of aminoglycosides. 115 According to the types of reactions and the functional groups they attack, three forms of such enzymes have been described (Figure 4 ): aminoglycoside phosphoryltransferase (APH), aminoglycoside nucleotidyltransferase (ANT) and aminoglycoside acetyltransferase (AAC). 114 Various protein sequences have been found within each type that are related to different resistance profiles. Accordingly, each class is further sub-classified into different types and are designated by numbers, Roman numerals and letters (Table 4) . For example, AAC(6 0 ) acts by acetylation of amino group at 6 0 of aminoglycosides; I, II, III … denote a particular resistance profile; and a, b, c … denote unique protein designations. Thus, AAC(3)-Ia and AAC(3)-Ib have the same resistance profile but vary in their amino acid composition. 115 A functional similarity has been found between AMEs produced by pathogenic Gram-negative bacteria and aminoglycosideproducing Actinomycetes. 116 This suggests that aminoglycoside resistance genes originated from organisms that naturally produce aminoglycosides. These genes are often carried on plasmids and/or MGEs, allowing them to disseminate rapidly among bacteria. 117 Furthermore, the MGEs that carry genes for these enzymes have often been associated with the genetic determinants for resistance to other related or unrelated antibiotics. 114, 118 A common gentamicin resistance acetyltransferase gene of P. aeruginosa, aac(3) is associated with a chromosomally located transposon (Tn801) which also carries a beta-lactamase gene (bla ). 119 Furthermore, in a burn isolate of P. aeruginosa, aac(3)-I was located in an integron which also contained other aminoglycoside resistance genes. 120 Similarly, the gene aph(3 0 ) which confers resistance to kanamycin, neomycin and streptomycin and ant(3 00 ) which confers resistance to streptomycin and gentamicin were carried on MGEs that were associated with beta-lactamase resistance. 121, 122 More recently, a whole genome sequence of multidrug-resistant P. aeruginosa from a urine sample demonstrated that this isolate harboured a class 1 integron (In113) carrying aac(6 0 )-Iae and bla IMP-1 , which are responsible for high levels of resistance to aminoglycosides and beta-lactams, respectively. 123 The prevalence of AMEs in aminoglycoside-resistant P. aeruginosa has been reported to be as high as 75 per cent. 124 In a separate study of Gramnegative bacteria including P. aeruginosa, 94 per cent of isolates carried AMEs coding genes in plasmids. 125 Many new variants of these enzymes have been detected in MGEs of P. aeruginosa in non-ocular isolates. [126] [127] [128] However, similar studies in ocular isolates are scarce. A variety of AME genes such as aadA1, aph(3 0 )-IIb, aph(3 0 )-I, aph (6) 
FLUOROQUINOLONE RESISTANCE
The fluoroquinolones target DNA topoisomerases of bacteria and are broadspectrum antibiotics. They have gained popularity in ophthalmology to treat ocular bacterial infections and can be used as a monotherapy instead of combinational therapy. 129, 130 In particular, ciprofloxacin is a common treatment regimen for microbial keratitis associated with contact lens wear. 11, 85 Due to its extensive use, continuous accumulation of resistance in various clinical isolates is being reported worldwide. The rate of ciprofloxacin resistance in clinical isolates of P. aeruginosa is more than 20 per cent in the USA. 131 Although the rate of fluoroquinolone resistance in eye isolates of P. aeruginosa is lower than those of other systemic infections, a high level of ciprofloxacin resistance has been reported in certain regions of the world. 26, 37, 42 Ciprofloxacin resistance up to 31 per cent has been reported in ocular Pseudomonas species from India and the rate of resistance has been increasing over time. 61 Resistance to fluoroquinolones developed in bacteria by three different mechanisms: mutations that alter the drug target sites (DNA gyrase and topoisomerase IV), changes that reduce the permeability of the membrane, and transfer of plasmids that carry resistance genes. 15, 129, 131 Mutations in quinolone-resistance determining regions (QRDRs) of the genes for topoisomerase II and IV are a major cause of resistance to fluoroquinolones of medically important isolates of P. aeruginosa.
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Plasmid-mediated quinolone resistance was first identified in a clinical isolate of Klebsiella pneumoniae and the responsible gene was qnr. 133 The Qnr protein can bind to DNA gyrase and topoisomerase IV and protects them from inhibition by fluoroquinolones. 134 Jacoby et al. reported that plasmids also carry genes that encode for beta-lactamases, one of the possible reasons for the occurrence of a high level of fluoroquinolone resistance in ESBL-producing bacteria. 131 Many variants of qnr genes (qnrA, qnrB, qnrC, qnrS and qnrD) have been isolated from Gram-negative bacteria. 135 Plasmidmediated quinolone resistance has been found in environmental P. putida and found to be transferable to E. coli. 136 To date, no evidence of the presence of plasmid-mediated qnr has been found in P. aeruginosa. 135 Various mutations in QRDRs were reported as the cause of resistance to fluoroquinolone 137 in an ocular isolate, but further studies are needed to elucidate acquired fluoroquinolone resistance in ocular P. aeruginosa.
CONCLUSION
While ocular P. aeruginosa infections can usually be effectively treated with antibiotics from three classes (beta-lactam, aminoglycoside and fluoroquinolones), P. aeruginosa can develop resistance against members of these important antibiotic classes in general infections. Genetic mutation and inter/ intra-species transfer of MGEs are responsible for the emergence and rapid spread of resistance.
Excessive use of antibiotics in clinical treatments and in agricultural fields has been noted as an important cause for emergence of resistance in bacteria. 62 Moreover, if resistance genes appear in a species, they are not limited to that one species, but can be transferred to other species. This creates a threat of a global pandemic of resistant ocular isolates. Increasing drug resistance in P. aeruginosa creates an immediate therapeutic threat because drug-resistant isolates are more difficult to treat 138 and resolution of disease is slower. 139 Analysis of plasmids and related MGEs will help understand the origin of resistance in strains. It is interesting to note that MGEs can contain genes, such as qacEdelta1 (Figure 1 ), related to resistance to disinfectants such as polyquaternary ammonium compounds that are used in contact lens disinfecting systems. These genes are common in multiple antibioticresistant strains of P. aeruginosa, 140 although possession of these types of genes does not necessarily result in increase in resistance to disinfectants. 140 However, possession of qac genes in ocular staphylococci does correlate to reduced sensitivity to disinfecting solutions. It will be interesting in future studies to examine relationships between qac genes and antibiotic genes to determine whether the exposure of P. aeruginosa to disinfectants as might occur during daily wear of contact lenses contributes to the dissemination of antibioticresistant genes.
Knowledge of resistance mechanisms is essential to prevent or slow the rate of spreading of resistance in bacteria, either by temporally changing the antibiotic regimen or replacing the antibiotic for which bacteria have mechanisms for dissemination.
